118 related articles for article (PubMed ID: 36220520)
1. DoE-based development of celecoxib loaded PLGA nanoparticles: In ovo assessment of its antiangiogenic effect.
Alonso-González M; Fernández-Carballido A; Quispe-Chauca P; Lozza I; Martín-Sabroso C; Isabel Fraguas-Sánchez A
Eur J Pharm Biopharm; 2022 Nov; 180():149-160. PubMed ID: 36220520
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Explorative Assessment of Celecoxib-Based Biocompatible Lipidic Nanocarriers for the Management of CFA-Induced Rheumatoid Arthritis in Wistar Rats.
Nirbhavane P; Sharma G; Singh B; Khuller GK; Goni VG; Patil AB; Katare OP
AAPS PharmSciTech; 2018 Oct; 19(7):3187-3198. PubMed ID: 30143947
[TBL] [Abstract][Full Text] [Related]
3. Formulation and optimization of celecoxib-loaded PLGA nanoparticles by the Taguchi design and their in vitro cytotoxicity for lung cancer therapy.
Emami J; Pourmashhadi A; Sadeghi H; Varshosaz J; Hamishehkar H
Pharm Dev Technol; 2015 Nov; 20(7):791-800. PubMed ID: 24841045
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
Liu Y; Sun C; Hao Y; Jiang T; Zheng L; Wang S
J Pharm Pharm Sci; 2010; 13(4):589-606. PubMed ID: 21486533
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel celecoxib-loaded nanosuspension using a wet media milling process.
Jeong SC; Kim DS; Jin SG; Youn YS; Oh KT; Li DX; Yong CS; Oh Kim J; Kim KS; Choi HG
Pharmazie; 2018 Sep; 73(9):498-502. PubMed ID: 30223931
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Delivery of Docetaxel and Celecoxib by PLGA Porous Microparticles for Their Synergistic Effects Against Lung Cancer.
Ziaei E; Emami J; Rezazadeh M; Kazemi M
Anticancer Agents Med Chem; 2022; 22(5):951-967. PubMed ID: 34382530
[TBL] [Abstract][Full Text] [Related]
7. Biocompatibility and intradiscal application of a thermoreversible celecoxib-loaded poly-N-isopropylacrylamide MgFe-layered double hydroxide hydrogel in a canine model.
Willems N; Yang HY; Langelaan ML; Tellegen AR; Grinwis GC; Kranenburg HJ; Riemers FM; Plomp SG; Craenmehr EG; Dhert WJ; Papen-Botterhuis NE; Meij BP; Creemers LB; Tryfonidou MA
Arthritis Res Ther; 2015 Aug; 17(1):214. PubMed ID: 26290179
[TBL] [Abstract][Full Text] [Related]
8. Sustained release of locally delivered celecoxib provides pain relief for osteoarthritis: a proof of concept in dog patients.
Tellegen AR; Rudnik-Jansen I; Utomo L; Versteeg S; Beukers M; Maarschalkerweerd R; van Zuilen D; van Klaveren NJ; Houben K; Teske E; van Weeren PR; Karssemakers-Degen N; Mihov G; Thies J; Eijkelkamp N; Creemers LB; Meij BP; Tryfonidou MA
Osteoarthritis Cartilage; 2023 Mar; 31(3):351-362. PubMed ID: 36473675
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of multiple drug resistance inhibitors by polymer/inorganic hybrid nanoparticles to effectively reverse cancer drug resistance.
Wu C; Gong MQ; Liu BY; Zhuo RX; Cheng SX
Colloids Surf B Biointerfaces; 2017 Jan; 149():250-259. PubMed ID: 27768915
[TBL] [Abstract][Full Text] [Related]
10. Novel multiparticulate pH triggered delayed release chronotherapeutic drug delivery of celecoxib-β-cyclodextrin inclusion complexes by using Box-Behnken design.
Maqbool I; Akhtar M; Ahmad R; Sadaquat H; Noreen S; Batool A; Khan SU
Eur J Pharm Sci; 2020 Apr; 146():105254. PubMed ID: 32023488
[TBL] [Abstract][Full Text] [Related]
11. Transethosomal Gel for the Topical Delivery of Celecoxib: Formulation and Estimation of Skin Cancer Progression.
Abdellatif AAH; Aldosari BN; Al-Subaiyel A; Alhaddad A; Samman WA; Eleraky NE; Elnaggar MG; Barakat H; Tawfeek HM
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678651
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure.
McCarron PA; Donnelly RF; Marouf W
J Microencapsul; 2006 Aug; 23(5):480-98. PubMed ID: 16980271
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic Acid-Decorated Glycol Chitosan Nanoparticles for pH-Sensitive Controlled Release of Doxorubicin and Celecoxib in Nonsmall Cell Lung Cancer.
Lee R; Choi YJ; Jeong MS; Park YI; Motoyama K; Kim MW; Kwon SH; Choi JH
Bioconjug Chem; 2020 Mar; 31(3):923-932. PubMed ID: 32027493
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N
Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284
[TBL] [Abstract][Full Text] [Related]
15. Colon targeting of celecoxib nanomixed micelles using pulsatile drug delivery systems for the prevention of inflammatory bowel disease.
El-Hady SM; AbouGhaly MHH; El-Ashmoony MM; Helmy HS; El-Gazayerly ON
Int J Pharm; 2020 Feb; 576():118982. PubMed ID: 31870958
[TBL] [Abstract][Full Text] [Related]
16. Fabrication and evaluation of lipid nanoparticulates for ocular delivery of a COX-2 inhibitor.
Sharma AK; Sahoo PK; Majumdar DK; Sharma N; Sharma RK; Kumar A
Drug Deliv; 2016 Nov; 23(9):3364-3373. PubMed ID: 27128623
[TBL] [Abstract][Full Text] [Related]
17. New celecoxib multiparticulate systems to improve glioblastoma treatment.
Vera M; Barcia E; Negro S; Marcianes P; García-García L; Slowing K; Fernández-Carballido A
Int J Pharm; 2014 Oct; 473(1-2):518-27. PubMed ID: 25066075
[TBL] [Abstract][Full Text] [Related]
18. Employment of Alginate Floating
Abdul Rasool BK; Khalifa A; Abu-Gharbieh E; Khan R
Biomed Res Int; 2020; 2020():1879125. PubMed ID: 32596281
[TBL] [Abstract][Full Text] [Related]
19. Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers.
Patlolla RR; Chougule M; Patel AR; Jackson T; Tata PN; Singh M
J Control Release; 2010 Jun; 144(2):233-41. PubMed ID: 20153385
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib-Loaded Solid Lipid Nanoparticles for Colon Delivery: Formulation Optimization and In Vitro Assessment of Anti-Cancer Activity.
Alajami HN; Fouad EA; Ashour AE; Kumar A; Yassin AEB
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
